Xenetic Biosciences Inc
NASDAQ:XBIO
Xenetic Biosciences Inc
NASDAQ:XBIO
Price:
3.608 USD
-2.75%
Market Closed
Updated:
May 20, 2024
Xenetic Biosciences Inc
Research & Development
|
Xenetic Biosciences Inc
Research & Development Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
Research & Development
-$3.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Research & Development
-$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Research & Development
-$6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Research & Development
-$5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Research & Development
-$3.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Research & Development
-$4.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
See Also
What is Xenetic Biosciences Inc's Research & Development?
Research & Development
-3.5m
USD
-3.5m
USD
Based on the financial report for Dec 31, 2023, Xenetic Biosciences Inc's Research & Development amounts to -3.5m USD.
What is Xenetic Biosciences Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-4%
-4%
Over the last year, the Research & Development growth was 27%. The average annual Research & Development growth rates for Xenetic Biosciences Inc have been -26% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
